Rapid Communication
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 21, 2006; 12(39): 6366-6370
Published online Oct 21, 2006. doi: 10.3748/wjg.v12.i39.6366
Table 1 Demographic characteristics of the study patients randomized to MBZ and QC at admission
MBZ groupQC group
n = 61n = 61
Sex
Male: n (%)28 (45.9)26 (42.6)
Female: n (%)33 (54.1)35 (57.3)
Age (yr)
Mean (range)8.2 (5-15)9.7 (5-15)
Table 2 Cure rates and drug-related adverse events reported by treatment groups
MBZ groupQC group
n = 61n = 61
Cure rate48 (78.7%)51 (83.6%)
Any adverse event14 (22.9%)36 (59%)
Abdominal pain11 (18 %)10 (16.3%)
Vomiting3 (4.9%)14 (22.9%)
Nausea3 (4.9%)14 (22.9%)
Headache1 (1.6%)11 (18%)
Yellowish coloration of the skin-15 (24.6%)